Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDKF10004/01
Compound5% Lidocaine medicated plaster
Trials sponsorGrünenthal GmbH
Trial phase3
Brief titleEfficacy and safety of intravenous neridronic acid in CRPS
IndicationPostherpetic neuralgia
UTN
CTG IDNCT03745404
CTIS ID (former EudraCT)
Trial statusCompleted
FPIApril 29, 2003
LPOJune 30, 2004
CountriesFrance, Germany, Poland, Spain, United Kingdom
GenderAll
Age>= 18 years of age
ResultsNo
Pubmed
Documents